Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Brand-name prescription medicine

Temodar

Generic name: Temozolomide

FDA application holder: Merck Sharp Dohme

Official data, not advice

Everything here comes from the U.S. Food and Drug Administration (FDA): the NDC Directory, Drugs@FDA, the official labels and recall reports; pharmacy costs come from the Centers for Medicare & Medicaid Services (CMS). Each fact shows its source and date.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or switch any medicine, including a switch between a brand and a generic.

In an emergency, call 911. If someone may have taken too much of a medicine, call Poison Help: 1‑800‑222‑1222.

Quick answers

What is Temodar?
Temodar is a brand name of Temozolomide, a prescription medicine. The FDA NDC Directory lists 7 Temodar products in 7 strengths and forms.
Who makes Temodar?
Merck Sharp Dohme holds the FDA application for Temodar (NDA021029, approved August 11, 1999).
Is there a generic or store brand of Temodar?
Yes. The FDA NDC Directory lists 64 other products with the same active ingredients, strength and form as a Temodar product, 64 of them generic. Ask your pharmacist whether one is right for you.
Has Temodar been recalled?
FDA enforcement reports list 1 recall of Temodar products; the newest started December 12, 2012. A recall usually concerns specific lots, not every product.

What Temodar is

Each Temodar product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.

Temozolomide · prescription medicine

Strength and formProduct namesSame medicine, other namesLabel
temozolomide 100 mg
capsule (oral)
Temodar 11 products, 11 companies DailyMed
temozolomide 140 mg
capsule (oral)
Temodar 11 products, 11 companies DailyMed
temozolomide 180 mg
capsule (oral)
Temodar 11 products, 11 companies DailyMed
temozolomide 2.5 mg/mL
injection, powder, lyophilized, for solution (intravenous)
Temodar None listed DailyMed
temozolomide 20 mg
capsule (oral)
Temodar 10 products, 10 companies DailyMed
temozolomide 250 mg
capsule (oral)
Temodar 11 products, 11 companies DailyMed
temozolomide 5 mg
capsule (oral)
Temodar 10 products, 10 companies DailyMed

Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Temozolomide →

FDA approval

  • NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
FDA applications of Temodar products (Drugs@FDA)
ApplicationHolderFirst approvedProducts
NDA021029Merck Sharp DohmeAugust 11, 19996
NDA022277Merck Sharp DohmeFebruary 27, 20091

Companies that list Temodar

The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Temodar products.

Recalls

From FDA enforcement reports, matched by the product’s NDC code or label. A recall usually covers specific lots: check the lot number on your package and ask your pharmacist. Do not stop a medicine on your own.

  1. December 12, 2012 · Class II · Terminated · D-139-2013

    Failed Impurities/Degradation Specifications: The recall is being initiated due to an out-of-specification result in the degradation product testing detected during stability monitoring.

    Temodar (temozolomide) Capsule, 20 mg per capsule, 5 capsules per package, For Oral Administration, Rx Only, Cytotoxic, NDC: 0085-1519-02, Schering Corporation, Kenilworth, New Jersey, 07033 — Schering-Plough Products, LLC

Sources

  1. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  2. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  3. Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  4. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
  5. NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026

Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.

Report an error → · Information for medicine makers